Global Injection Pen Market By Device Type (Disposable Injection Pens and Reusable Injection Pens), By Application (Diabetes, Growth Hormonal Therapies, Autoimmune Diseases, Fertility Treatments, Osteoporosis, Anaphylaxis, Obesity and Others), By Age Group (Pediatric, Adult and Geriatric), By End-User (Hospitals, Home Use and Clinics), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Dec 2025
- Report ID: 172433
- Number of Pages: 222
- Format:
-
keyboard_arrow_up
-
-
- Novo Nordisk A/S
- Eli Lilly and Company
- Sanofi S.A.
- Becton, Dickinson and Company
- Ypsomed Holding AG
- Merck KGaA
- AstraZeneca
- Owen Mumford Ltd.
- Pfizer Inc.
- Biocon Biologics Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Ltd.
- Novartis AG
- Haselmeier GmbH
- Wockhardt Ltd.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible